Nutra Pharma Corp (NPHC) Change in Cash (2010 - 2026)

Nutra Pharma has disclosed Change in Cash across 13 years of filings, most recently posting -$21844.0 for Q2 2026.

• In Q2 2026, Change in Cash fell 133.49% year-over-year to -$21844.0; the TTM figure through Jun 2026 stood at -$79069.0 (down 345.75% YoY), while the FY2025 annual figure was -$24266.0, down 166.58% from the prior year.
• Change in Cash came in at -$21844.0 for Q2 2026 at Nutra Pharma, down from $9663.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $65226.0 in Q2 2025 to a low of -$83971.0 in Q1 2022.
• Average Change in Cash over 3 years is -$14150.8, with a median of -$10448.0 recorded in 2022.
• Year-over-year, Change in Cash slumped 4898.34% in 2022 and soared 142.75% in 2026.
• Over 3 years, Change in Cash stood at -$10448.0 in 2022, then soared by 182.1% to $8578.0 in 2025, then tumbled by 354.65% to -$21844.0 in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$21844.0 in Q2 2026, $9663.0 in Q1 2026, and $8578.0 in Q4 2025.